Gilead and Merck announce successful HIV treatment trial results

June 8, 2026 4:35 PM

Gilead Sciences Inc. (NASDAQ: GILD) and Merck & Co. Inc. (NYSE: MRK) reported that their investigational once-weekly oral HIV treatment ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found